These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 21064429)
61. Variation in the modification of cardiovascular responses by sympathetic inhibitory drugs. Prichard BN Proc R Soc Med; 1969 Jan; 62(1):84-91. PubMed ID: 5763482 [No Abstract] [Full Text] [Related]
62. Adrenergic pharmacology of aqueous humor dynamics. Potter DE Pharmacol Rev; 1981 Sep; 33(3):133-53. PubMed ID: 7323134 [No Abstract] [Full Text] [Related]
63. Sympatholytic therapy in primary hypertension: a user friendly role for the future. DeQuattro V; Li D J Hum Hypertens; 2002 Mar; 16 Suppl 1():S118-23. PubMed ID: 11986908 [TBL] [Abstract][Full Text] [Related]
64. The adrenergic receptors. Sapeika N S Afr Med J; 1969 Dec; ():Suppl:3-6. PubMed ID: 4392022 [No Abstract] [Full Text] [Related]
65. Steric aspects of adrenergic drugs. XI. Interactions of dibenamine and beta adrenergic blockers. Patil PN; Tye A; May C; Hetey S; Miyagi S J Pharmacol Exp Ther; 1968 Oct; 163(2):309-19. PubMed ID: 4386625 [No Abstract] [Full Text] [Related]
66. [Current status of knowledge concerning adrenergic beta receptor inhibitors]. Malcolm J; Malcolm-Thomas B; Comhaire E Acta Cardiol; 1970; 25(3):260-79. PubMed ID: 4393666 [No Abstract] [Full Text] [Related]
67. Adrenergic neurone blocking activity of some new guanidine derivatives. Kadzielawa K; Gumulka W Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):287-96. PubMed ID: 4294770 [No Abstract] [Full Text] [Related]
68. [On some sympatholytics belonging to the phenyl thio-l-diethyl-amino-2-ethane series]. BUCHEL L; TCHOUBAR B C R Seances Soc Biol Fil; 1947 Jan; 141(1-2):34. PubMed ID: 20268197 [No Abstract] [Full Text] [Related]
70. [Differentiation of the effects of sympathicotropic drugs]. MEIER R Dtsch Med Wochenschr; 1947 Jan; 72(1-4):42. PubMed ID: 20342315 [No Abstract] [Full Text] [Related]
71. The differentiation of sympathicotropic drug action. MEIER R Schweiz Med Wochenschr; 1946; 76(37-38):860-5. PubMed ID: 21000468 [No Abstract] [Full Text] [Related]
72. [The differentiation of the action of sympathicotropic pharmaceutical preparations]. MEIER R Med Hyg (Geneve); 1946 Oct; 4(83):2. PubMed ID: 20343271 [No Abstract] [Full Text] [Related]
73. The pharmacology of a series of new sympatholytic agents (tertiary amines). NICKERSON M; GOODMAN LS Proc Am Fed Clin Res; 1945; 2():109. PubMed ID: 20275649 [No Abstract] [Full Text] [Related]
74. The sympathetic nervous system as a target for the treatment of hypertension and cardiometabolic diseases. Sorota S J Cardiovasc Pharmacol; 2014 May; 63(5):466-76. PubMed ID: 24805148 [TBL] [Abstract][Full Text] [Related]
75. Physiological properties of a new series of sympatholytic agents. NICKERSON M; GOODMAN LS Fed Proc; 1946; 5(1 Pt 2):194. PubMed ID: 21064429 [No Abstract] [Full Text] [Related]
76. Relation of structure to activity in a new series of sympatholytic agents. NICKERSON M; NOMAGUCHI G; GOODMAN LS Fed Proc; 1946; 5(1 Pt 2):195. PubMed ID: 20983204 [No Abstract] [Full Text] [Related]
77. The pharmacology of a series of new sympatholytic agents. NICKERSON M; GOODMAN LS Rocky Mt Med J; 1947 Apr; 44(4):290. PubMed ID: 20290044 [No Abstract] [Full Text] [Related]